← Vertex Pharmaceuticals

What podcasts say about Vertex Pharmaceuticals

Every statement, with the speaker, the exact quote and the moment it was said.

What experts have said about Vertex Pharmaceuticals

5 statements · 2 positive · 3 neutral

  1. Dan CurtisNeutralJul 7, 2026· Stock Movers

    Vertex agreed to acquire Crinetics for $10 billion in cash.

    “Vertex has agreed to buy Crenex for $10 billion in cash.”

    Listen at 3:54

    Open the episode · Micron and Sandisk Drop; SpaceX Rating; Crinetics Soars
  2. Dan CurtisPositiveJul 7, 2026· Stock Movers

    The Crinetics acquisition will give Vertex entry into endocrinology.

    “This will give Vertex an entry into the endocrinology market.”

    Listen at 4:09

    Open the episode · Micron and Sandisk Drop; SpaceX Rating; Crinetics Soars
  3. Billy LipschultzPositiveJul 6, 2026· Stock Movers

    Vertex Pharmaceuticals agreed to acquire Kinetics Pharma for $85 per share.

    “Vertex Pharmaceuticals agreeing to acquire kinetics Pharma for 85 bucks a share.”

    Listen at 1:07

    Open the episode · Crinetics Gains on Vertex Deal, Solstice Acquire Element, Terawulf Jumps
  4. Billy LipschultzNeutralJul 6, 2026· Stock Movers

    The Vertex-Kinetics deal has approximately $10 billion equity value, or $8.8 billion net of cash.

    “the driver for that total equity value, about $10 billion, 8.8 billion net of estimated cash.”

    Listen at 1:25

    Open the episode · Crinetics Gains on Vertex Deal, Solstice Acquire Element, Terawulf Jumps
  5. Billy LipschultzNeutralJul 6, 2026· Stock Movers

    Vertex had a $134 billion market capitalization before the deal.

    “$134 billion market cap prior to this deal.”

    Listen at 1:48

    Open the episode · Crinetics Gains on Vertex Deal, Solstice Acquire Element, Terawulf Jumps

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Vertex Pharmaceuticals: what podcasts say · PodLume